Patents Assigned to Invectys SA
  • Anti HLA-G specific antibodies
    Patent number: 11634494
    Abstract: The present invention relates to antibodies, or antigen-binding fragments thereof, directed against human leukocyte antigen-G (HLA-G) protein and raised against an immunogenic peptide derived from the ?3 domain of HLA-G protein. The invention further relates to the immunogenic peptide, and methods for producing said anti-HLA-G specific antibodies.
    Type: Grant
    Filed: April 25, 2022
    Date of Patent: April 25, 2023
    Assignee: Invectys SA
    Inventors: Pierre Langlade Demoyen, Thierry Huet, Julien Caumartin, Maria Loustau, Maria Wehbe
  • Chimeric antigen receptors against multiple HLA-G isoforms
    Patent number: 11505608
    Abstract: The present invention relates to chimeric antigen receptors (CAR) against multiple but not all human leukocyte antigen (HLA-G) isoforms. More specifically, the invention concerns CARs that are specific for HLA-G ?2M-free or ?2M-associated immunosuppressive isoforms respectively.
    Type: Grant
    Filed: May 9, 2022
    Date of Patent: November 22, 2022
    Assignee: Invectys SA
    Inventors: Maria Loustau, François Anna, Pierre Langlade Demoyen, Julien Caumartin
  • Chimeric antigen receptors against multiple HLA-G isoforms
    Patent number: 11325977
    Abstract: The present invention relates to chimeric antigen receptors (CAR) against multiple but not all human leukocyte antigen (HLA-G) isoforms. More specifically, the invention concerns CARs that are specific for HLA-G ?2M-free or ?2M-associated immunosuppressive isoforms respectively.
    Type: Grant
    Filed: September 10, 2021
    Date of Patent: May 10, 2022
    Assignee: Invectys SA
    Inventors: Maria Loustau, François Anna, Pierre Langlade Demoyen, Julien Caumartin
  • Anti HLA-G specific antibodies
    Patent number: 11312774
    Abstract: The present invention relates to antibodies, or antigen-binding fragments thereof, directed against human leukocyte antigen-G (HLA-G) protein and raised against an immunogenic peptide derived from the ?3 domain of HLA-G protein. The invention further relates to the immunogenic peptide, and methods for producing said anti-HLA-G specific antibodies.
    Type: Grant
    Filed: September 3, 2021
    Date of Patent: April 26, 2022
    Assignee: Invectys SA
    Inventors: Pierre Langlade Demoyen, Thierry Huet, Julien Caumartin, Maria Loustau, Maria Wehbe
  • Chimeric antigen receptors against multiple HLA-G isoforms
    Patent number: 11117971
    Abstract: The present invention relates to chimeric antigen receptors (CAR) against multiple but not all human leukocyte antigen (HLA-G) isoforms. More specifically, the invention concerns CARs that are specific for HLA-G ?2M-free or ?2M-associated immunosuppressive isoforms respectively.
    Type: Grant
    Filed: October 22, 2020
    Date of Patent: September 14, 2021
    Assignee: Invectys SA
    Inventors: Maria Loustau, François Anna, Pierre Langlade Demoyen, Julien Caumartin
  • Anti HLA-G specific antibodies
    Patent number: 11111302
    Abstract: The present invention relates to antibodies, or antigen-binding fragments thereof, directed against human leukocyte antigen-G (HLA-G) protein and raised against an immunogenic peptide derived from the ?3 domain of HLA-G protein. The invention further relates to the immunogenic peptide, and methods for producing said anti-HLA-G specific antibodies.
    Type: Grant
    Filed: October 26, 2020
    Date of Patent: September 7, 2021
    Assignee: Invectys SA
    Inventors: Pierre Langlade Demoyen, Thierry Huet, Julien Caumartin, Maria Loustau, Maria Wehbe